"Diketopiperazines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Piperazines with two keto oxygens.
| Descriptor ID |
D054659
|
| MeSH Number(s) |
D03.383.606.385
|
| Concept/Terms |
Diketopiperazines- Diketopiperazines
- Piperazinediones
- Diketopiperazine Compounds
- Diketopiperazine
|
Below are MeSH descriptors whose meaning is more general than "Diketopiperazines".
Below are MeSH descriptors whose meaning is more specific than "Diketopiperazines".
This graph shows the total number of publications written about "Diketopiperazines" by people in this website by year, and whether "Diketopiperazines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diketopiperazines" by people in Profiles.
-
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan; 28(1):e26401.
-
Preferences for oral and injectable PrEP among qualitative sub-study participants in HPTN 084. PLoS One. 2024; 19(10):e0309811.
-
Two-drug regimens for the treatment of HIV in Africa. Lancet HIV. 2024 Jun; 11(6):e419-e426.
-
The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants. AIDS. 2024 03 15; 38(4):589-594.
-
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022 05 07; 399(10337):1779-1789.